Recent Advances in Therapy of Schizophrenia

Author(s): Mahesh T. Chhabria, Vishranti D. Trivedi

Journal Name: Current Psychiatry Reviews
Continued as Current Psychiatry Research and Reviews

Volume 7 , Issue 1 , 2011


Despite great progress in basic schizophrenia research, the conclusive identification of specific etiological factors or a pathogenic process in the illness has remained elusive. The convergence of modern neuroscientific studies in molecular genetics, molecular neuropathology, neurophysiology, in vivo brain imaging, and psychopharmacology, however, indicates that we may be coming much closer to understanding the molecular basis of schizophrenia. Schizophrenia may be a neurodevelopmental and progressive disorder with multiple biochemical abnormalities involving the dopaminergic, serotonin, glutamate, and γ-aminobutyric acidergic systems. In the near future, biological markers for the illness may come from the combination of diverse assessment techniques. An understanding of the pathophysiology of schizophrenia will be essential to the discovery of preventive measures and therapeutic intervention. Rapidly advancing research into schizophrenia includes diverse etiological hypotheses, and offers directions for future research and treatments.

Keywords: Schizophrenia, dopamine, serotonin, glutamate, GABA, aminobutyric acidergic systems, biological markers, etiological hypotheses, psychotomimetics, Tourette's syndrome

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [25 - 42]
Pages: 18
DOI: 10.2174/157340011795945856

Article Metrics

PDF: 24